Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)
CAPS Rating:
A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases
A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases
Recs
No buyout in sight and negative earnings paint a difficult future.